ACL/PCL Reconstruction Devices Market Size, Share and Trends Analysis | United States | 2020-2026 | MedCore | Includes: Allograft Products, and Fixation Devices
- Year: 2020
- Scope: 10 Years
- Region: United States
- Type: MedCore
The U.S ACL/PCL reconstruction device market size is estimated to increase over the forecast period to reach $360 million by 2026. The knee is the most susceptible joint to pressure and injury in the human body, as its bending capacity is a result of complex interactions of rotational and extensional movements. The anterior and posterior cruciate ligaments (ACL/PCL) connect the bones that form the knee, stabilizing joint movements and preventing the femur from sliding against the tibia and vice versa.
The majority of the U.S ACL/PCL reconstruction device market share was controlled by Arthrex, MTF Biologics, and Smith & Nephew. The total ACL/PCL reconstruction market includes allograft products and fixation devices. Allografts are further segmented into BTB, non-sutured soft tissue, and pre-sutured tendon allografts. The fixation device market is divided into the interference screw, cortical fixation, intratunnel fixation, washer and post and cross-pin device segments.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Analysis and Forecasts until 2026, Utilizing Historical Data from 2016 (10-year span)
- Market Drivers and Limiters
- Competitive Market Share Analysis
- Company Profiles and Product Portfolios
- Leading Competitors
ACL/PCL reconstruction MARKET INSIGHTS
The most common ACL/PCL procedure involves one graft product and two fixation devices for the tibial and femoral side, respectively. Graft options are primarily focused on autograft and allograft products. Both autograft and allograft options are recognized as a standard approach for ACL/PCL procedures. The combined ACL/PCL reconstruction market includes the revenue from the fixation devices and the revenue from allograft products only. The autograft approach is considered in terms of total ACL/PCL procedures and as a related portion of the fixation devices. Procedures performed with allografts represent around 30% of the total number of ACL/PCL reconstructions, while autografts are used in the remaining 70%.
ACL/PCL reconstruction MARKET SHARE INSIGHTS
Arthrex, MTF Biologics, and Smith & Nephew controlled the U.S ACL/PCL reconstruction device market share.
Arthrex dominated the total fixation market and was the fourth-leading competitor in the allograft market, due to the company’s dominance in the emerging pre-sutured allograft tendon market. The companies strong presence in the ACL/PCL fixation device market was due to its leading positions in the interference screw segment, with the BioComposite™ device.
RESEARCH REGIONAL COVERAGE
Throughout this report, iData Research has covered researched the U.S. in great detail. The region covered is:
- North America (the United States)
| Arthrex |
| MTF Biologics |
| Smith & Nephew |
| DePuy Mitek |
| RTI Surgical |
| LifeNet Health |
| JRF Ortho |
| Zimmer Biomet |
| CONMED |
| Others |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
ACL/PCL Reconstruction Devices Market Size, Share and Trends Analysis | United States | 2020-2026 | MedCore | Includes: Allograft Products, and Fixation Devices
$3,995 – $5,995
The U.S ACL/PCL reconstruction device market size is estimated to increase over the forecast period to reach $360 million by 2026. The total ACL/PCL reconstruction market includes allograft products and fixation devices. Allografts are further segmented into BTB, non-sutured soft tissue, and pre-sutured tendon allografts. The fixation device market is divided into the interference screw, cortical fixation, intratunnel fixation, washer, and post and cross-pin device segments.
- 2020
- 10 Years
- United States
- MedCore
Related Reports
